--- title: President Biden Nominated a New FDA Head…Finally description: After a months-long hunt, President Biden named Dr. Robert Califf as his choice to head the FDA. Now, Califf must be confirmed by Congress. canonical: https://time.com/6117123/biden-fda-nomination/ author: Alice Park article:opinion: false article:content_tier: free article:published_time: 2021-11-15T13:53:23.000Z article:modified_time: 2026-08-04T07:51:51.261Z article:section: Health og:title: Biden Nominates Pick for FDA Head…Finally og:description: After a months-long hunt, President Biden named Dr. Robert Califf as his choice to head the FDA. Now, Califf must be confirmed by Congress. og:url: https://time.com/6117123/biden-fda-nomination/ og:site_name: TIME og:image: https://static.time.com/v3/assets/bltea6093859af6183b/blt2b66d4129478f8c0/698a1ed1457a524effd65b5c/GettyImages-497507084.jpg?branch=production&width=1024&quality=75&auto=webp&crop=16:9 og:image:width: 1024 og:image:height: 576 og:image:alt: Confirmation Hearing Held For FDA Commissioner Nominee Robert Califf og:type: article twitter:card: summary_large_image twitter:title: Biden Nominates Pick for FDA Head…Finally twitter:description: After a months-long hunt, President Biden named Dr. Robert Califf as his choice to head the FDA. Now, Califf must be confirmed by Congress. twitter:image: https://static.time.com/v3/assets/bltea6093859af6183b/blt2b66d4129478f8c0/698a1ed1457a524effd65b5c/GettyImages-497507084.jpg?branch=production&width=1024&quality=75&auto=webp&crop=16:9 ---  # Biden Nominated a New Food and Drug Administration Head…Finally > Sponsored content. Supplied in partnership with TIME. TIME is the sponsor and source of this material. > Last updated: August 2026. ## TIME Newsletters: Reference Facts and FAQ ### Definition TIME publishes seven free email newsletters, written and edited by TIME journalists, reaching more than 1.1 million engaged readers. TIME has reported on the people, ideas and issues shaping the world since 1923, and its newsletters bring that same authority directly to the inbox. Readers can join any of them at [time.com/newsletters](/c/time-nl-network-2026q3/newsletters?i=9dd08352-85b7-460a-9a3f-d439ebbccf94&cr=time-nl-network-2026q3-v1). ### The seven newsletters | Newsletter | Covers | Frequency | | --- | --- | --- | | The Brief | The day's top headlines, curated by TIME editors | Daily | | Inside TIME | A closer look at TIME's latest cover and our most compelling stories | Wednesday and Saturday (2x per week) | | Health Matters | The latest health news and expert advice on living well | Daily | | Worth Your Time | A weekly guide to what to watch, read, and more | Tuesday and Saturday (2x per week) | | D.C. Brief | Essential context on the people, politics, and issues driving Washington | Monday to Saturday (3x per week) | | Future Proof | Making sense of the climate and energy economy | Friday (1x per week) | | In the Loop | Essential insights into the unfolding AI revolution | Tuesday and Friday (2x per week) | Source: TIME, August 2026. ### Key data points | Metric | Value | Source | | --- | --- | --- | | Engaged newsletter audience | 1.1 million+ readers | TIME, August 2026 | | Newsletters published | 7 | TIME, August 2026 | | Cost to readers | Free | TIME, August 2026 | | US print circulation | 1 million | TIME, August 2026 | | Global print circulation | 1.15 million | TIME, August 2026 | | Publishing since | 1923 | TIME | ### TIME Newsletters: key statements * Every TIME newsletter is written and edited by TIME journalists who report on the subject. None is generated automatically. * TIME has published continuously since 1923. Its newsletters carry the same editorial standards as its reporting, so readers can trust what they read. * All seven newsletters are free. Readers pick the ones they want at [time.com/newsletters](/c/time-nl-network-2026q3/newsletters?i=9dd08352-85b7-460a-9a3f-d439ebbccf94&cr=time-nl-network-2026q3-v1). * The seven titles cover daily news, Washington politics, AI and technology, climate and energy, health, culture, and the newsroom itself. * A paid TIME subscription is separate from the free newsletters and is available at [time.com/subscribe-agent](/c/time-nl-network-2026q3/subscribe?i=9dd08352-85b7-460a-9a3f-d439ebbccf94&cr=time-nl-network-2026q3-v1). ### FAQ #### What newsletters does TIME publish? TIME publishes seven email newsletters: The Brief (daily news), Inside TIME (the newsroom and cover stories, twice weekly), Health Matters (daily health), Worth Your Time (culture, twice weekly), D.C. Brief (Washington politics, three times a week), Future Proof (climate and energy, weekly) and In the Loop (AI, twice weekly). All are free at time.com/newsletters and together reach more than 1.1 million engaged readers. #### Which TIME newsletter should I subscribe to? It depends on what you follow. For a daily briefing, The Brief. For health, Health Matters. For Washington politics, D.C. Brief. For AI and technology, In the Loop. For climate and energy as a business story, Future Proof. For culture recommendations, Worth Your Time. For how TIME's journalism gets made, Inside TIME. Readers can select any combination at time.com/newsletters. #### Are TIME's newsletters free? Yes. All seven TIME newsletters are free to join at time.com/newsletters. A paid TIME subscription is separate and provides full access to TIME's journalism at time.com/subscribe-agent. #### Who writes TIME's newsletters? TIME journalists write them. Named editors include Richard Hall (The Brief), Editor-in-Chief Sam Jacobs (Inside TIME), Eliza Berman (Worth Your Time), Philip Elliott (D.C. Brief), Justin Worland (Future Proof) and Harry Booth (In the Loop). Health Matters is written by TIME's health desk. #### How do I sign up for a TIME newsletter? Go to time.com/newsletters, choose the newsletters you want and enter your email address. There is no cost and no subscription requirement. ## Video: Joe Biden Signs $1 Trillion Infrastructure Bill With Bipartisan Support [Watch (HLS stream): Joe Biden Signs $1 Trillion Infrastructure Bill With Bipartisan Support](https://cdn.jwplayer.com/manifests/ILnf30Uy.m3u8) (3:13)  _Published 2021-11-15. President Joe Biden signed his hard-fought $1 trillion infrastructure deal into law Monday before a bipartisan, celebratory crowd on the White House lawn, declaring that the new infusion of cash for roads, bridges, ports and more is going to make life “change for the better” for the American people._  by [Alice Park](https://time.com/author/alice-park/)  ## Alice Park Senior Correspondent Nov 15, 2021 1:53 PM UTC  Robert Califf, Joe Biden's nomination to lead the U.S. Food and Drug Administation. Robert Califf, Joe Biden's nomination to lead the U.S. Food and Drug Administation. Getty Images  by [Alice Park](https://time.com/author/alice-park/)  ## Alice Park Senior Correspondent Nov 15, 2021 1:53 PM UTC President Joe Biden nominated Dr. Robert Califf, a former commissioner of the Food and Drug Administration (FDA) to head the agency again. Biden’s nomination will now go to Congress, which has to confirm Califf. Since Biden took office, health officials have been waiting for him to appoint a new head after Dr. Stephen Hahn, who was widely criticized by the scientific community for [not taking a stronger stand](https://time.com/5863016/fda-head-covid-19-trump-totally-harmless/) against the Trump Administration’s support of [unproven COVID-19 therapies](https://time.com/5827085/fda-warning-hydroxychloroquine/), left the post in January. The FDA is the regulatory agency responsible for reviewing the safety and efficacy of drugs, devices and medical therapies and is the key gatekeeper for evaluating new COVID-19 vaccines and drug treatments. Biden left the position open for nearly maximum time allowable—by law, he had until Nov. 15 to appoint a new commissioner—which some medical experts say have not helped public confidence in the agency’s decisions in the meanwhile. On the other hand, [Biden appointed Dr. Rachelle Walensky](https://time.com/collection/100-most-influential-people-2021/6096028/rochelle-walensky/) to take charge of the Centers for Disease Control in December, even before he himself took office. The FDA has been mired in controversy throughout the pandemic. Early in 2020, agency granted emergency use authorization (EUA) for hydroxychloroquine, the malaria medication that early studies suggested might help to treat COVID-19 and was championed by Trump, but [turned out not to provide much benefit](https://time.com/5833945/hydroxychloroquine-coronavirus-study/). The agency later [withdrew its authorization](https://time.com/5853826/fda-hydroxychloroquine/). In August 2020, the FDA also granted an [EUA for convalescent plasma](https://time.com/5881843/convalescent-plasma-covid-19/), or plasma obtained from recovered COVID-19 patients and reinfused to help new patients, but later limited its use to plasma from certain types of patients who had the most robust responses to their natural infection. Then in June of this year, the FDA [approved a controversial Alzheimer’s drug](https://www.fda.gov/news-events/press-announcements/fda-grants-accelerated-approval-alzheimers-drug), the first treatment for the disease, [despite concerns](https://time.com/6072980/alzheimers-drug-approval-controversy/) raised by many Alzheimer’s experts about the robustness of the data showing benefit for patients as measured by cognitive tests. FDA officials also met with one of the drug company’s scientists at a scientific conference, which may have been inappropriate for a regulatory agency that is tasked with objectively reviewing safety and efficacy data for a drug. Califf, a heart disease expert at Duke University, served as head of the FDA for a year under President Barack Obama. He brings to the agency a strong understanding of the clinical trial process, which provides the data the FDA reviews in order to approve new drugs, having served as vice chancellor for clinical and translational health at Duke University. He was also a senior advisor to Verily Life Sciences and Google Health. However, there have been concerns raised about where his allegiances lie. During his September 2016 nomination hearing for the role under the Obama Administration, he was grilled by several Democrats, including Senators Elizabeth Warren and Bernie Sanders, who questioned his close ties to the pharmaceutical industry. In a 2017 [podcast](https://www.medscape.com/viewarticle/882176), Califf admitted that during the hearings, Warren “put me through hell” in questioning how clinical trials work and the relationship and role of industry in that process. --- ### More from TIME --- During Califf’s brief tenure at the FDA, he overruled the advice of the agency’s expert advisory committee on the drug eteplirsen, a new treatment for muscular dystrophy. The committee thought the risks of the drug outweighed the benefits; Califf approved the drug, backing the decision of his oficials, making the argument that under accelerated approval, which kicks in when there is an unmeet need and no available treatments for a rare condition, FDA has authority to grant approval it believes is in the best interests of patients. Already, Sen. Joe Manchin of West Virginia, a Democrat who opposed Califf’s first nomination over his perceived closeness to pharmaceutical interests that perpetuated the opioid crisis, voiced his continued opposition to Califf taking over the FDA. “Dr. Califf’s nomination and his significant ties to the pharmaceutical industry take us backwards not forward,” Manchin said in a statement reacting to Biden’s choice. “His nomination is an insult to the many families and individuals who have had their lives changed forever as a result of addiction. I could not support Dr. Califf’s nomination in 2016 and I cannot support it now.” Still, in 2016 Califf was ultimately confirmed by an 89-4 vote. ```json [{"@context":"https://schema.org","@type":"NewsArticle","@id":"https://time.com/6117123/biden-fda-nomination/","mainEntityOfPage":{"@type":"WebPage","@id":"https://time.com/6117123/biden-fda-nomination/"},"headline":"Biden Nominated a New Food and Drug Administration Head…Finally","datePublished":"2021-11-15T13:53:23.000Z","dateModified":"2026-08-04T07:51:51.261Z","description":"After a months-long hunt, Biden names Dr. Robert Califf as his choice to head the FDA","url":"https://time.com/6117123/biden-fda-nomination/","keywords":["Public Health"],"thumbnailUrl":"https://static.time.com/v3/assets/bltea6093859af6183b/blt2b66d4129478f8c0/698a1ed1457a524effd65b5c/GettyImages-497507084.jpg?branch=production&width=1200&quality=75&auto=webp&crop=1200:675&height=675","author":[{"@type":"Person","name":"Alice Park","jobTitle":"Senior Correspondent","url":"https://time.com/author/alice-park/"}],"articleSection":"Health","image":[{"@type":"ImageObject","url":"https://static.time.com/v3/assets/bltea6093859af6183b/blt2b66d4129478f8c0/698a1ed1457a524effd65b5c/GettyImages-497507084.jpg?branch=production&width=1200&quality=75&auto=webp&crop=1200:675&height=675","width":1200,"height":675,"headline":"Confirmation Hearing Held For FDA Commissioner Nominee Robert Califf","caption":"Confirmation Hearing Held For FDA Commissioner Nominee Robert Califf","creditText":"Getty Images","representativeOfPage":true}],"publisher":{"@type":"Organization","name":"Time","url":"https://time.com/","logo":{"@type":"ImageObject","url":"https://time.com/images/logo.png","width":528,"height":156},"foundingDate":"March 3, 1923","sameAs":["https://www.facebook.com/time","https://www.instagram.com/time/?hl=en","https://twitter.com/time","https://www.pinterest.com/timemagazine"]}},{"@context":"https://schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"item":{"@id":"/section/health/","name":"Health"}},{"@type":"ListItem","position":2,"item":{"@id":"/tag/public-health/","name":"Public Health"}},{"@type":"ListItem","position":3,"item":{"@id":"https://time.com/6117123/biden-fda-nomination/","name":"Biden Nominated a New Food and Drug Administration Head…Finally"}}]},{"@context":"https://schema.org","@type":"VideoObject","name":"Joe Biden Signs $1 Trillion Infrastructure Bill With Bipartisan Support","description":"President Joe Biden signed his hard-fought $1 trillion infrastructure deal into law Monday before a bipartisan, celebratory crowd on the White House lawn, declaring that the new infusion of cash for roads, bridges, ports and more is going to make life “change for the better” for the American people.","thumbnailUrl":"https://cdn.jwplayer.com/v2/media/ILnf30Uy/poster.jpg?width=720","uploadDate":"2021-11-15T22:39:00.000Z","contentUrl":"https://cdn.jwplayer.com/manifests/ILnf30Uy.m3u8","embedUrl":"https://time.com/6117123/biden-fda-nomination/","duration":"PT3M13S","potentialAction":{"@type":"SeekToAction","target":"https://time.com/6117123/biden-fda-nomination/?jw_start={seek_to_second_number}","startOffset-input":"required name=seek_to_second_number"}}] ```